<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Mutational analysis of cfDNA to identify predictive biomarkers in previously untreated patients with metastatic pancreatic cancer receiving the GSK-3 inhibitor elraglusib (9-ING-41) in combination with gemcitabine/nab-paclitaxel in the 1801 phase 2 study	</title>
	<atom:link href="https://www.tempus.com/publications/mutational-analysis-of-cfdna-to-identify-predictive-biomarkers-in-previously-untreated-patients-with-metastatic-pancreatic-cancer-receiving-the-gsk-3-inhibitor-elraglusib-9-ing-41-in-combination-wit/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.tempus.com/publications/mutational-analysis-of-cfdna-to-identify-predictive-biomarkers-in-previously-untreated-patients-with-metastatic-pancreatic-cancer-receiving-the-gsk-3-inhibitor-elraglusib-9-ing-41-in-combination-wit/</link>
	<description>AI-enabled precision medicine</description>
	<lastBuildDate>Thu, 23 May 2024 22:51:12 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/

Page Caching using Disk: Enhanced (Page is feed) 

Served from: www.tempus.com @ 2025-03-24 21:04:20 by W3 Total Cache
-->